The purpose of this national diagnosis and treatment protocol (PNDS) is to outline to health providers the optimum management and integrated care pathway for patients with long-term conditions (ALD), particularly with status ALD 11: xeroderma pigmentosum (XP).
See also
HAS opinions and decisions
17/06/2009
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
yXRV0JxZ9wgZmcFe
